Sinopharm Group Co. Ltd. | Cash Flow
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,830
7,469
9,213
10,428
11,730
14,460
Depreciation, Depletion & Amortization
854
1,051
1,169
1,173
1,171
1,652
Other Funds
672
398
660
1,046
759
3,369
Funds from Operations
5,745
6,958
8,404
8,857
9,716
12,742
Changes in Working Capital
1,360
2,558
5,926
149
10,198
12,633
Net Operating Cash Flow
4,385
4,400
14,330
8,707
481
110
Capital Expenditures
1,643
2,375
1,600
1,594
2,365
Sale of Fixed Assets & Businesses
112
28
231
1,288
1,827
Purchase/Sale of Investments
826
15
4
420
352
Net Investing Cash Flow
5,294
5,656
1,950
1,996
2,202
Cash Dividends Paid - Total
810
840
1,058
1,326
1,595
Issuance/Reduction of Debt, Net
7,532
1,489
4,556
2,717
9,027
Net Financing Cash Flow
6,314
2,798
6,274
346
6,446
Net Change in Cash
5,300
1,548
6,168
7,036
3,781
Free Cash Flow
2,961
2,574
13,071
7,292
2,499
Net Assets from Acquisitions
468
382
576
1,369
1,352
Other Sources
12
1
-
98
40
Change in Capital Stock
264
5,526
-
-
226
Exchange Rate Effect
105
6
63
21
19
Other Uses
2,480
2,913
9
-
-
About Sinopharm Group Co.
View Profile
